(Date:12/2/2009)... S*BIO Pte Ltd today announced data presentations on ... Society of Hematology 51st Annual Meeting and Exposition in ... clinical results from the Phase 1 dose-escalation trial of ... in dose levels ranging from 100 to 600 mg. ...
(Date:12/2/2009)... Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) ... endocrine therapy and oncology, today announced that the ... Fast Track designation for the Company,s PI3K/Akt pathway ... relapsed/refractory multiple myeloma. Keryx Biopharmaceuticals, Inc. ("Keryx") ( ...
(Date:12/2/2009)... N.J., Dec. 2 According to the National Institute of ... diabetes already have some stage of diabetic retinopathy. Diabetic ... is a major cause of blindness in people with diabetes ... In fact, up to 80 percent of all patients who,ve ...
(Date:12/1/2009)... that a new market research report is available ... Global Market Trends ,, http://www.reportlinker.com/p0164494/Chromium---Global-Market-Trends.html ... influenced by stainless steel, while growth in aerospace ... for growth of chromium metal. Environmental constraints and ...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9... BOTHELL, WA, and VANCOUVER, April 9 /PRNewswire-FirstCall/ - OncoGenex ... OGXI ), announced today that it has been named ... LifeSciences British Columbia. This annual award is presented by ... has made outstanding contributions to the development of British ...
... a provider of nanoproteomic analysis systems to life science ... Series C financing led by its largest shareholder, the ... Partners, Novo A/S, Mitsui Ventures, Royal Bank of Canada ... are very happy to announce this financing in the ...
... April 9 Cepheid (Nasdaq: CPHD ) ... fiscal first quarter ended March 31, 2009, on Thursday, April ... host a management presentation at 2 p.m. Pacific Time on ... access the live webcast, please visit Cepheid,s website at ...
Other Biology Technology:OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia 2OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia 3Cell Biosciences Closes $10 Million Series C Financing 2Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast 2The imaging screen-K (Kodak), is a 35 x 43 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
The external laser upgrade for the Molecular Imager FX adds a 635 nm external laser; the 555 nm long pass filter is replaced with a 605 nm band pass filter to distinguish Cy5 from 532 nm excitable dy...
The HQ505, 20 OptiGreen filter for the Molecular Imager FX is a band pass filter used for detection of Cy2 and FITC with 532 nm excitation....
The filter 605DF50 for the Molecular Imager FX is a band pass filter for ethidium bromide, SYPRO Red, SYPRO Ruby, Alexa Fluor 532 and 546, and Cy3 dyes when using the 635 nm laser....
Biology Products: